A cross-sectional study on knowledge and practice of caregivers of under-5 children regarding EPI
Abstract
Background: The Expanded Programme on Immunization (EPI) is one of the most successful and cost effective public health interventions for vaccine-preventable diseases of under-5 children in Bangladesh. Complete and timely immunization of under-5 children largely depends upon the knowledge and practice of caregivers’ regarding vaccination. Evaluating caregivers’ knowledge and practices regarding EPI is necessary to find out the gaps and enhance immunization services. Objective: To assess the knowledge and practice of caregivers of under-5 children regarding EPI at Bangladesh Shishu Hospital & Institute, Dhaka. Methods: It was a descriptive cross-sectional study conducted from 8th to 22nd February 2025 among caregivers of under-5 children attending the outpatient department (OPD) and EPI centre of Bangladesh Shishu Hospital and Institute, Dhaka. The knowledge and practice of the caregivers regarding EPI were assessed using 8 questions on knowledge and 5 on practice, assigning a score of 1 for each correct response and 0 for each incorrect response. Purposive sampling technique was used for data collection and the final sample size was 148. The data were analysed via SPSS (version 31.0). Results: The mean age of the under-5 children was 16.12±12.37 months (mean±SD) and the majority (53.4%) of under-5 children were aged 0-12 months. The study population included 50.7% males and 49.3% females. The majority were Muslim (72.3%) and resided in urban areas (70.3%). More than…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.